250 related articles for article (PubMed ID: 31338966)
1. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs.
Gao X; Wang J; Li M; Wang J; Lv J; Zhang L; Sun C; Ji J; Yang W; Zhao Z; Mao W
J Cell Mol Med; 2019 Oct; 23(10):6797-6804. PubMed ID: 31338966
[TBL] [Abstract][Full Text] [Related]
2. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
Zhang Z; Sun C; Zhang L; Chi X; Ji J; Gao X; Wang Y; Zhao Z; Liu L; Cao X; Yang Y; Mao W
Biomed Pharmacother; 2019 Jan; 109():1541-1546. PubMed ID: 30551406
[TBL] [Abstract][Full Text] [Related]
3. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis.
Zhao Y; Jing Z; Li Y; Mao W
Oncol Rep; 2016 Jul; 36(1):567-72. PubMed ID: 27177238
[TBL] [Abstract][Full Text] [Related]
4. Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma
Ali R; Al-Kawaz A; Toss MS; Green AR; Miligy IM; Mesquita KA; Seedhouse C; Mirza S; Band V; Rakha EA; Madhusudan S
Cancer Res; 2018 Dec; 78(24):6818-6827. PubMed ID: 30297533
[TBL] [Abstract][Full Text] [Related]
5. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo.
Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W
Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092
[TBL] [Abstract][Full Text] [Related]
6. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
7. Baicalin attenuates XRCC1-mediated DNA repair to enhance the sensitivity of lung cancer cells to cisplatin.
Yin Z; Chen E; Cai X; Gong E; Li Y; Xu C; Ye Z; Cao Z; Pan J
J Recept Signal Transduct Res; 2022 Jun; 42(3):215-224. PubMed ID: 33719846
[TBL] [Abstract][Full Text] [Related]
8. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
[TBL] [Abstract][Full Text] [Related]
10. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.
Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J
Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731
[TBL] [Abstract][Full Text] [Related]
11. The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.
Orta ML; Höglund A; Calderón-Montaño JM; Domínguez I; Burgos-Morón E; Visnes T; Pastor N; Ström C; López-lázaro M; Helleday T
Nucleic Acids Res; 2014 Aug; 42(14):9108-20. PubMed ID: 25074383
[TBL] [Abstract][Full Text] [Related]
12. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway.
Gao X; Zhang C; Wang Y; Zhang P; Zhang J; Hong T
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802664
[TBL] [Abstract][Full Text] [Related]
13. Effect of berberine on p53 expression by TPA in breast cancer cells.
Kim S; Han J; Kim NY; Lee SK; Cho DH; Choi MY; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE
Oncol Rep; 2012 Jan; 27(1):210-5. PubMed ID: 21964832
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects.
Ma W; Zhang Y; Yu M; Wang B; Xu S; Zhang J; Li X; Ye X
Int Immunopharmacol; 2020 Oct; 87():106787. PubMed ID: 32707493
[TBL] [Abstract][Full Text] [Related]
15. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
[TBL] [Abstract][Full Text] [Related]
16. Genomic screening for targets regulated by berberine in breast cancer cells.
Wen CJ; Wu LX; Fu LJ; Yu J; Zhang YW; Zhang X; Zhou HH
Asian Pac J Cancer Prev; 2013; 14(10):6089-94. PubMed ID: 24289631
[TBL] [Abstract][Full Text] [Related]
17. Plant Isoquinoline Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549 Cell Line.
Kalaiarasi A; Anusha C; Sankar R; Rajasekaran S; John Marshal J; Muthusamy K; Ravikumar V
J Agric Food Chem; 2016 Dec; 64(50):9542-9550. PubMed ID: 27936791
[TBL] [Abstract][Full Text] [Related]
18. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner.
Sims JT; Ganguly S; Fiore LS; Holler CJ; Park ES; Plattner R
Biochem Pharmacol; 2009 Aug; 78(3):249-60. PubMed ID: 19427998
[TBL] [Abstract][Full Text] [Related]
19. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway.
Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY
J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
